Avecho Biotechnology Ltd has released a press release.
Progress Update for TPM Cannabinoid Development Program
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- June 2020 Quarterly Activities Report & Appendix 4C
- March 2020 Quarterly Activities Report & Appendix 4C
- Changes to Leadership Team
- Medicinal cannabis supply agreement with Tasmanian Alkaloids
- Avecho signs Term Sheet for Cannabinoid Supply with Purisys
Later from Avecho Biotechnology
- TPM Cannabinoid Development Program Update
- September 2020 Quarterly Activities Report & Appendix 4C
- Improved Propofol TPM Formulation Passes Toxicology Study
- AVE begins Human Trial on CBD product
- December 2020 Quarterly Activities Report & Appendix 4C
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology